Options traders are betting on biotechnology declines over the next two months in large size. With XBI implied volatility at three year lows, the put options selected by these traders are historically inexpensive. But like most hedging strategies, they have negative options backtesting results as they generally lose money over long time horizons. The maximum historical payout for these hedging trades would be 6x premium paid.
View options backtestOptions traders expect a 5% Nike price move after earnings
Options traders are pricing in a 5% move in Nike's stock after they report earnings tomorrow. This is nothing unusual as options traders have priced in an earnings move within the tight range of 4-6% since 2012. Options backtesting shows that selling volatility in advance of their earnings has generally only been a mildly profitable strategy.
View options backtest